Framingham Company Receives Approval To Start Exploratory Biopsy Study in Europe
editor In full transparency, the following is a press release submitted to SOURCE through its business wire service. *** FRAMINGHAM – Xenetic Biosciences, a Framingham-bsed biopharmaceutical company focused on advancing XCART,…